BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025.
Hayes, 64, is currently the executive chairman of the board of directors of RTX Corporation, the world’s largest aerospace and defense company. He brings more than 30 years of extensive executive experience, having held chief executive officer and senior leadership roles across finance, corporate strategy and business development functions, as well as leadership of large and complex businesses undergoing transformative initiatives, including M&A and spinoff transactions. Hayes’ appointment to the BD board of directors is in line with the company’s ongoing commitment to strong corporate governance and regular board refreshment. With this appointment, the BD board of directors has added four new, independent directors since 2021.
“Greg will join the board at a pivotal time in BD’s transformation, as we seek to unlock significant shareholder value through the planned separation of our Diagnostic Solutions and Biosciences business and launch of the ‘New BD’ as a medtech leader representing the foundation and future of health care,” said Tom Polen, chairman, CEO and president of BD. “Greg’s proven track record of portfolio optimization, strategic excellence and driving operational efficiency is well aligned with the BD Excellence operating system and our deep commitment to a culture of continuous improvement. He will be an invaluable asset to our board of directors and the future success of BD.”
Prior to his appointment to the RTX board of directors, Hayes’ career at United Technologies Corporation (UTC) spanned two decades, culminating in his appointment to chief executive officer in 2014 and chairman in 2016. As CEO, Hayes was instrumental in the formation of RTX — the result of the 2020 merger of UTC’s aerospace businesses, Pratt & Whitney and Collins Aerospace, with Raytheon Company. Hayes, who joined UTC in 1999 through its merger with the Sundstrand Corporation, also served as UTC’s chief financial officer from 2008 to 2014. He also serves on the board of directors for Phillips 66 Company.
“BD has a remarkable 125-year history as a leading manufacturer of medical devices and is critical to the infrastructure of our health care system,” said Hayes. “We have an incredible opportunity ahead, and I look forward to leveraging my experience to help oversee a successful separation and establish ‘New BD’ as a differentiated and focused pure-play medtech company that is positioned to accelerate innovation, drive profitable growth and deliver long-term sustainable value for all stakeholders.”
Hayes earned a bachelor’s degree in Economics from Purdue University and is a certified public accountant.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
